No results displayed.
Inside "Interviews with Patients and Researchers":
@CancerQuest on Twitter:
Related to this page:
Was this page helpful?
|
Page 16 of 45 | <Previous : Next> Jump to Page:

Interview with Dr. David Flockhart

Dr. David Flockhart
Harry and Edith Gladstein Chair in Cancer Genomics
Professor of Medicine, Medical Genetics and Pharmacology
Indiana University School of Medicine &
Division of Clinical Pharmacology
Wishard Memorial Hospital

Dr. Flockhart's research focuses on the individual ways that different people respond to cancer treatments.  The differences are important in predicting the outcome of the treatment and is based, in part, on their genetic make-up.  Pharmacogenomics is a field that studies this relationship and Dr. Flockhart is developing new tools to study this interaction.  Ultimately his work could yield new treatments or better ways to use existing treatments.  He would like treatments to be personalized for each patient and discusses this in our interview.

Image of Dr. David Flockhart

Questions and Answers

About Dr. Flockhart(Time: 12 sec)
How did you first get interested in medical science as a career?(Time: 57 sec)
How did you become involved in the field of pharmacogenomics?(Time: 1 min 29 sec)
What is pharmacogenomics?(Time:  1 min 40 sec)
Why do people respond differently to different drugs?(Time: 2 min 28 sec)
On what types of cancer does your research focus?(Time: 1 min)
How would a cancer patient benefit from your research?(Time: 3 min 55 sec)
Are you satisfied with the progress in your field of research?(Time:  2 min 24 sec)
What do you foresee for the future of pharmacogenomics?(Time: 12 sec)
Page 16 of 45 | <Previous : Next>
Last Modified: 10/08/2010 Print Email Page Share
Copyright ©2012 Emory University. All rights reserved.
Direct questions and comments to cancerquest@emory.edu.
Disclaimer | Legal Policies | Contact
Follow @CancerQuest on Twitter
CancerQuest Dictionary
Follow us on: